A detailed history of Keb Asset Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Keb Asset Management, LLC holds 1,000 shares of LLY stock, worth $746,200. This represents 0.31% of its overall portfolio holdings.

Number of Shares
1,000
Previous 850 17.65%
Holding current value
$746,200
Previous $769,000 15.08%
% of portfolio
0.31%
Previous 0.3%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$772.14 - $960.02 $115,821 - $144,003
150 Added 17.65%
1,000 $885,000
Q2 2024

Jul 25, 2024

BUY
$724.87 - $909.04 $253,704 - $318,164
350 Added 70.0%
850 $769,000
Q2 2023

Jul 28, 2023

BUY
$350.74 - $468.98 $175,370 - $234,490
500 New
500 $234,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Keb Asset Management, LLC Portfolio

Follow Keb Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keb Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keb Asset Management, LLC with notifications on news.